Cordycepin inhibits colon cancer proliferation by suppressing MYC expression
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cordycepin inhibits colon cancer proliferation by suppressing MYC expression
Authors
Keywords
-
Journal
BMC Pharmacology & Toxicology
Volume 23, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-05
DOI
10.1186/s40360-022-00551-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MYC as a Target for Cancer Treatment
- (2021) Michael J Duffy et al. CANCER TREATMENT REVIEWS
- Alternative polyadenylation: methods, mechanism, function, and role in cancer
- (2021) Yi Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Intratumor CMS Heterogeneity Impacts Patient Prognosis in Localized Colon Cancer
- (2021) Laetitia Marisa et al. CLINICAL CANCER RESEARCH
- The long journey to bring a Myc inhibitor to the clinic
- (2021) Jonathan R. Whitfield et al. JOURNAL OF CELL BIOLOGY
- Early-onset colorectal cancer: initial clues and current views
- (2020) Lorne J. Hofseth et al. Nature Reviews Gastroenterology & Hepatology
- Anti‐inflammatory effects of cordycepin: A review
- (2020) Lu Tan et al. PHYTOTHERAPY RESEARCH
- miR-26a promotes hepatocellular carcinoma invasion and metastasis by inhibiting PTEN and inhibits cell growth by repressing EZH2
- (2019) Wen-Tao Zhao et al. LABORATORY INVESTIGATION
- Therapeutic Potential and Biological Applications of Cordycepin and Metabolic Mechanisms in Cordycepin-Producing Fungi
- (2019) Peng Qin et al. MOLECULES
- MicroRNA-26a is a key regulon that inhibits progression and metastasis of c-Myc/EZH2 double high advanced hepatocellular carcinoma
- (2018) Xiang Zhang et al. CANCER LETTERS
- The Anticancer Properties of Cordycepin and Their Underlying Mechanisms
- (2018) So Yoon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine?
- (2018) Chiara Molinari et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC
- (2017) Kiyotoshi Satoh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cordycepin protects PC12 cells against 6-hydroxydopamine induced neurotoxicity via its antioxidant properties
- (2016) Opeyemi J. Olatunji et al. BIOMEDICINE & PHARMACOTHERAPY
- Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseases
- (2016) Ferenc Sipos et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Targeting Translation Initiation Bypasses Signaling Crosstalk Mechanisms That Maintain High MYC Levels in Colorectal Cancer
- (2015) A. Wiegering et al. Cancer Discovery
- MiR-26a Promotes Ovarian Cancer Proliferation and Tumorigenesis
- (2014) Wenjing Shen et al. PLoS One
- C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells
- (2013) Pin Guo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MYC stimulates EZH2 expression by repression of its negative regulator miR-26a
- (2008) S. Sander et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started